Priaxon AG
Office phone +49 89 4521****
Get Phone Number
Homepage http://www.priaxon.de
LinkedIn Profile https://linkedin.com/company/pr***on-***
HQ Location
Germany , Bayern, MünchenSiegfriedstraße 8, 80803 München, Germany
Priaxon AG drives small molecule drug R&D through the consequent early application of proprietary in silico methods to ligand interactions of interest, followed by the identification of pre-optimised modulators in novel chemical space. Focused hit-to-lead and lead optimisation stages allow rapid and cost effective generation of candidates with confirmed target interaction and target accessibility properties.
As such, the Priaxon technology is truly target-focused and not constricted by proprietary target/class specific chemistry or assay technology. It is particularly suited for, but not limited to, the modulation of protein-protein interactions and allosteric sites.
The Priaxon project pipeline focuses on Cancer/ Immunotherapy and Anti-infectives with novel modes of action.
Biotechnology and Molecular Biology Research
Companies in the biotechnology and molecular biology industry use advanced technologies to research and develop products that are used to diagnose or treat diseases. This also involves gene manipulation which can be used to create new medicines or vaccines.
Career Opportunities at Priaxon AG
Stay updated on the latest job openings by checking back regularly or by visiting the company's official career page.
No job listings currently found.
Employees of 'Priaxon AG'
Decision makers at Priaxon
1 Decision Makers at Priaxon
Purchasing & operations at Priaxon
1 Purchasing & Operations at Priaxon
Details of Priaxon
Related Companies and Competitors
Access All Contact Details
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive to ensure that the information is accurate and up-to-date, we cannot guarantee its completeness or accuracy. We do not endorse or guarantee the products or services of any company or individual listed.
